Show simple item record

dc.contributor.authorWinfield, JM
dc.contributor.authorBlackledge, MD
dc.contributor.authorTunariu, N
dc.contributor.authorKoh, D-M
dc.contributor.authorMessiou, C
dc.date.accessioned2021-05-18T15:43:18Z
dc.date.available2021-05-18T15:43:18Z
dc.date.issued2021-10-01
dc.identifier.citationClinical radiology, 2021
dc.identifier.issn0009-9260
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/4557
dc.identifier.eissn1365-229X
dc.identifier.doi10.1016/j.crad.2021.04.001
dc.description.abstractWhole-body magnetic resonance imaging (MRI) is now a crucial tool for the assessment of the extent of systemic malignant bone disease and response to treatment, and forms part of national and international recommendations for imaging patients with myeloma or metastatic prostate cancer. Recent developments in scanners have enabled acquisition of good-quality whole-body MRI data within 45 minutes on modern MRI systems from all main manufacturers. This provides complimentary morphological and functional whole-body imaging; however, lack of prior experience and acquisition times required can act as a barrier to adoption in busy radiology departments. This article aims to tackle the former by reviewing the indications and providing guidance for technical delivery and clinical interpretation of whole-body MRI for patients with malignant bone disease.
dc.formatPrint-Electronic
dc.languageeng
dc.language.isoeng
dc.publisherW B SAUNDERS CO LTD
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.titleWhole-body MRI: a practical guide for imaging patients with malignant bone disease.
dc.typeJournal Article
dcterms.dateAccepted2021-04-08
rioxxterms.versionVoR
rioxxterms.versionofrecord10.1016/j.crad.2021.04.001
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2021-04-29
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfClinical radiology
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublished
pubs.embargo.termsNot known
dc.contributor.icrauthorBlackledge, Matthew


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0